Bitter Tea: Why a US Customs Snag Is the Least of Wahaha’s Problems

The U.S. FDA’s detention of Wahaha products over prohibited sweeteners has exposed deeper cracks in the Chinese beverage giant’s operations. As the company navigates a fraught leadership transition and a massive overhaul of its distribution network, declining sales and internal institutional friction pose a greater threat than international regulatory hurdles.

Share
Portrait of an adult woman smiling in front of a colorful geometric wall indoors.

Key Takeaways

  • 1The FDA placed Wahaha tea on a detention list (Import Alert 99-45) due to the presence of cyclamate, a banned additive in the U.S.
  • 2Wahaha claims the products were exported by unauthorized distributors and that it has no official business presence in the United States.
  • 3Internal data reveals a dramatic 83% year-on-year decline in actual product deliveries to distributors in certain regions.
  • 4Successor Kelly Zong is aggressively restructuring the company, leading to the termination of roughly 4,000 distribution partnerships.
  • 5Ongoing institutional tension exists between the legacy Wahaha Group and Kelly Zong’s private entity, Hongsheng Group, over brand control and resources.

Editor's
Desk

Strategic Analysis

Wahaha is currently navigating the 'founder's trap' in the most public way possible. The transition from Zong Qinghou’s paternalistic, relationship-based management style to Kelly Zong’s data-driven, efficiency-focused approach is causing massive friction within China’s traditional retail ecosystem. The U.S. FDA incident is a classic example of a Chinese 'National Champion' being ill-prepared for the rigors of global compliance, but the real crisis is domestic. If Wahaha cannot stabilize its relationship with its distributors—who are currently refusing inventory despite paper-thin growth—the brand risks a rapid decline once the current wave of nostalgia-driven consumption fully dissipates. The shift of assets toward the Hongsheng Group also suggests a possible 'hollowing out' of the original group, which could lead to further legal and political complications in the near future.

China Daily Brief Editorial
Strategic Insight
China Daily Brief

For decades, Hangzhou Wahaha Group has been a cornerstone of the Chinese beverage market, a multi-billion dollar empire built on bottled water and sugary childhood nostalgia. However, recent weeks have seen the brand’s domestic dominance contrasted by a sharp setback abroad. The U.S. Food and Drug Administration (FDA) has placed Wahaha’s black tea and lemon products on a 'Detention Without Physical Examination' (DWPE) list, effectively banning them from entry at American ports. The trigger was cyclamate, an artificial sweetener that is legal in China and the European Union but has been banned in the United States since 1970.

Wahaha’s response to the seizure has been one of tactical distancing. A spokesperson for the company clarified that the tea was never intended for the U.S. market, characterizing the shipment as an unauthorized export by a rogue distributor. While technically plausible—many Chinese food products reach Western shelves via gray-market channels—the incident highlights a glaring regulatory gap. For a brand that aspires to international relevance, failing to control its supply chain or adapt its formulations to local laws is a significant reputational liability.

Yet, for those watching the company closely in China, the U.S. customs issue is merely a symptom of a much deeper malaise. Since the death of legendary founder Zong Qinghou in early 2024, the company has undergone a turbulent leadership transition to his daughter, Kelly Zong (Zong Fuli). The initial wave of patriotic consumerism that saw sales surge following the elder Zong's passing has begun to recede, leaving the company to face harsh market realities and internal restructuring that has alienated its once-loyal distribution network.

Internal documents leaked to Chinese media suggest a company in the midst of a violent overhaul. Reports indicate that Kelly Zong’s leadership has moved to 'streamline' operations, leading to the termination of approximately 4,000 distributors. More alarming are the financial indicators: while Wahaha reported high headline revenue for 2024, recent data suggests a precipitous drop in distributor fulfillment. In some provinces, actual delivery figures have plummeted by over 80% year-on-year, as distributors, squeezed by rising wholesale prices and stagnant retail margins, are increasingly refusing to take on new stock.

There is also the unresolved question of the 'two Wahahas.' The tension between the legacy Wahaha Group—a complex entity with state-linked minority stakes—and Kelly Zong’s wholly-owned Hongsheng Group has created a sense of strategic ambiguity. As core resources and management functions shift from the parent company to the daughter’s private vehicle, the brand's long-term stability is being questioned by partners and investors alike. The cyclamate scandal is an minor irritant compared to the risk of a systemic collapse of the distribution model that made Wahaha a household name.

Related Articles

📰
No related articles found